Shares of Colgate-Palmolive (India) Ltd. (COLPAL) declined by almost 3% on October 24, 2024, as investors await the company’s Q2FY25 earnings report. The market anticipates strong year-on-year growth, though recent weakness in the broader market has weighed on the stock.
Key Expectations for Colgate-Palmolive’s Q2FY25 Results:
- Revenue: Expected to rise to ₹1,634 crore, up from ₹1,462 crore in Q2FY24.
- EBITDA: Projected to improve to ₹543 crore compared to ₹482 crore last year.
- EBITDA Margin: Expected to show a slight increase at 33.23%, versus 32.97% in Q2FY24.
- Net Profit: Estimated to reach ₹396 crore, up from ₹340 crore a year ago.
Despite these optimistic expectations for the quarterly financial performance, the stock’s decline is largely attributed to investor caution ahead of the official numbers, and the overall bearish sentiment in the market today.
Outlook:
Colgate-Palmolive’s consistent financial performance has been buoyed by strong demand for its hygiene products, but rising input costs could potentially affect profitability margins. Investors are particularly focused on the company’s EBITDA margin and how it manages operational efficiencies in the face of cost pressures.